Treating neuroleptic malignant syndrome as catatonia [9]

Journal of Clinical Psychopharmacology

Volumn 21, Issue 1, 2001, Pages 121-122

  Fink, M ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMOBARBITAL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; DANTROLENE; DIAZEPAM; FLUMAZENIL; LEVODOPA; LORAZEPAM; NEUROLEPTIC AGENT;

CATATONIA; ELECTROCONVULSIVE THERAPY; HUMAN; LETTER; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; SEIZURE;

CATATONIA; DANTROLENE; DOPAMINE AGONISTS; HUMANS; MUSCLE RELAXANTS, CENTRAL; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 0035139702     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200102000-00028     Document Type: Letter

References (19)

1. The neuroleptic malignant syndrome
2. Specific treatment of the neuroleptic malignant syndrome
3. Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia
4. Catatonic syndrome in a general psychiatric population: Frequency, clinical presentation, and response to lorazepam
5. Catatonia and the neuroleptic malignant syndrome - A single entity?
6. Malignant catatonia
7. Neuroleptic malignant syndrome and catatonia: One entity or two?
8. Catatonia
9. The nondichotomy between lethal catatonia and neuroleptic malignant syndrome
10. Production of sleep and rest in psychotic cases
11. Electroconvulsive therapy of the lethal catatonia syndrome
12. Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome
13. Catatonia
14. Intravenous lorazepam in neuroleptic-induced catatonia
15. Untersuchungen zur frage der akuten tödlichen katatonie
16. Multiple ECT late in the course of neuroleptic malignant syndrome
17. Catatonia